share_log

SVB Securities Initiates Coverage On CureVac With Outperform Rating, Announces Price Target of $13

Benzinga ·  Jun 8, 2023 08:45

SVB Securities analyst Mani Foroohar initiates coverage on CureVac (NASDAQ:CVAC) with a Outperform rating and announces Price Target of $13.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment